High Serum S100A12 as a Diagnostic and Prognostic Biomarker for Severity, Multidrug-Resistant Bacteria Superinfection and Herpes Simplex Virus Reactivation in COVID-19

URN to cite this document:: urn:nbn:de:bvb:355-epub-590314
DOI to cite this document:: 10.5283/epub.59031

Mester, Patricia ; Keller, Dennis ; Kunst, Claudia ; Räth, Ulrich ; Rusch, Sophia ; Schmid, Stephan

; Krautbauer, Sabrina ; Müller, Martina ; Buechler, Christa

; Pavel, Vlad

License: Creative Commons Attribution 4.0
PDF - Published Version
(1MB)

Date of publication of this fulltext: 30 Aug 2024 16:38

Alternative links to fulltext:DOI Publisher

Details

Preview

Export bibliographical data

Abstract

Neutrophils are critical immune cells in severe coronavirus disease 2019 (COVID-19). S100 calcium-binding protein A12 (S100A12) is highly expressed in neutrophils during acute inflammation. The aim of this study was to evaluate serum S100A12 levels as a diagnostic and prognostic tool in COVID-19. Serum samples of patients with moderate and severe COVID-19 were collected during 2020 to 2024. ...